Efficacy and Safety of a New Sperm Capacitation Method
- Conditions
- Reproductive IssuesMale InfertilityAsthenozoospermiaOligozoospermiaTeratozoospermia
- Registration Number
- NCT06742437
- Lead Sponsor
- Fecundis Lab SL
- Brief Summary
Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Male
- Target Recruitment
- 300
- Ability to provide a semen sample via masturbation
- Current diagnosis of a sexually transmitted infection (STI)
- Previous diagnosis of hepatitis A, B, C, D, or HIV
- Prior participation in this study
- Participation in a clinical trial involving an intervention within the last 3 months
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hyperactivation 2 hours Percentage of sperm cells displaying hyperactivated motility
- Secondary Outcome Measures
Name Time Method Sperm vitality 2 hours Percentage of viable sperm cells
DNA fragmentation 2 hours Percentage of TUNEL-positive sperm cells
Sperm motility 2 hours Percentage of motile sperm cells
Survival 20 hours Percentage of motile sperm cells after overnight incubation
Trial Locations
- Locations (4)
Eugin Barcelona
🇪🇸Barcelona, Spain
Fertty
🇪🇸Barcelona, Spain
CIRH
🇪🇸Barcelona, Spain
Natuvitro
🇪🇸Barcelona, Spain